NCT04202341
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
- Locations
-
- Clinical Trial Site Birmingham, Alabama, United States
- Clinical Trial Site Scottsdale, Arizona, United States
- Clinical Trial Site Fresno, California, United States
- Clinical Trial Site Orange, California, United States